The efficiency of (18)F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer

PURPOSE: Investigate whether (18)F-FDG PET-CT has the potential to predict the major pathologic response (MPR) to neoadjuvant sintilimab in resectable NSCLC patients, and the potential of sifting patients who probably benefit from immunotherapy. METHODS: Treatment-naive patients with resectable NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Xiuli, Li, Ning, Wu, Ning, He, Jie, Ying, Jianming, Gao, Shugeng, Wang, Shuhang, Wang, Jie, Wang, Zhijie, Ling, Yun, Tang, Wei, Zhang, Zewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101299/
https://www.ncbi.nlm.nih.gov/pubmed/32043180
http://dx.doi.org/10.1007/s00259-020-04711-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101299/
https://www.ncbi.nlm.nih.gov/pubmed/32043180
http://dx.doi.org/10.1007/s00259-020-04711-3

Ejemplares similares